Other languages Comera Life Sciences Holdings, Inc.

Equities

CMRA

US20037C1080

Market Closed - OTC Markets Other stock markets 09:30:01 2024-05-17 EDT			5-day change	1st Jan Change
0.0292 ^USD	-4.72%		+9.33%	-46.73%

01-30	Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes	CI
01-30	Comera Life Sciences Holdings, Inc. Announces Changes to Its Board	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes	01-30
Comera Life Sciences Holdings, Inc. Announces Changes to Its Board	01-30
Comera Life Sciences Holdings, Inc. Appoints Dorothy Clarke to Board of Directors	11-13
Comera Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
Comera Life Sciences Holdings, Inc. Announces Resignation of Neal Muni, MD as Executive Vice President and Chief Operating Officer	23-10-06
Comera Life Sciences Holdings, Inc. Announces Publication of Study Reinforcing Caffeine's Viscosity Reducing Capabilities	23-08-16
Comera Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Comera Life Sciences Holdings, Inc. Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore(TM) Platform	23-08-08
Comera Life Sciences Holdings, Inc. Announces Collaboration with Quality Chemical Laboratories to Secure Proprietary Supply of SQore Excipients	23-07-20
Comera Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12
Comera Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	23-03-16
Insider Buy: Comera Life Sciences Holdings	23-01-06
Insider Buy: Comera Life Sciences Holdings	23-01-06
Comera Life Sciences Holdings, Inc. Announces Board Resignations	23-01-04
Comera Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10
Comera Life Sciences Appoints Janice Marie Mccourt as Chief Business Officer	22-11-09
Comera Life Sciences Holdings Says Study Shows SQore Excipient Causes No Local or Systemic Toxicity	22-10-18
Comera Life Sciences Holdings, Inc. Announces Favorable Preclinical Results of Lead SQore Excipient in SEQURUS-2 Study	22-10-18
Comera Life Sciences Expands Massachusetts Headquarters	22-10-04
Comera Life Sciences Holdings, Inc. Expands Woburn Operations	22-10-04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Comera Life Sciences Holdings, Inc.

Equities

CMRA

US20037C1080

Other languages

Filters